The UK has secured early access to 355m vaccine doses

Oxford/

AstraZeneca

BioNTech/

Pfizer

Novavax

Moderna

5m

100m

60m

40m

Phase 3

clinical trial

Phase 3

Phase 3

Phase 3

GSK/

Sanofi Pasteur

Janssen

Valneva

30m

60m

60m

Phase 2

Phase 1

Pre-clinical

Oxford/

AstraZeneca

BioNTech/

Pfizer

GSK/

Sanofi Pasteur

Novavax

Moderna

Janssen

Valneva

5m

100m

60m

40m

30m

60m

60m

Phase 3

clinical trial

Phase 3

Phase 3

Phase 3

Phase 2

Phase 1

Pre-clinical